Literature DB >> 24920376

Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts.

Cindy Parks Thomas1, Meelee Kim, Ruslan V Nikitin, Peter Kreiner, Thomas W Clark, Grant M Carrow.   

Abstract

PURPOSE: To describe prescriber response to unsolicited patient reports from the Massachusetts prescription drug monitoring program (PDMP).
METHODS: Prescribers were surveyed upon receipt of unsolicited reports of their patients' prescription history and three months later. We assessed prescribers' awareness of other prescribers listed in the report, their clinical assessment of medical necessity of all prescribed medications, actions taken by prescribers after receiving the report, and usefulness of the report.
RESULTS: Of the 333 respondents to the initial survey, only 28 (8.4%) were aware of most, all, or nearly all other prescribers. A total of 146 (43.8%) reported having sufficient knowledge to determine whether the prescriptions were medically necessary, of whom 102 (69.6%) felt the prescriptions were unwarranted. Of the 163 respondents to the follow-up survey, 31.3% added the report to the patient's file, 22.7% discussed the report with other prescribers on the report, 21.5% took no action, and 6% discussed the report with the patient (representing two-thirds of respondents who saw the patient after receiving the report). Most respondents felt that the report was useful for their practice and easy to understand.
CONCLUSIONS: Unsolicited reporting of PDMP data has the potential to improve clinical practice by alerting providers about patients with multiple prescribers and potentially medically unnecessary prescriptions.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  controlled medications; controlled substances; opioids; pharmacoepidemiology; prescription drug abuse; prescription drug monitoring; unsolicited reports

Mesh:

Substances:

Year:  2014        PMID: 24920376     DOI: 10.1002/pds.3666

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  9 in total

1.  Perception of prescription drug monitoring programs as a prevention tool in primary medical care.

Authors:  Amie J Goodin; Joshua D Brown; Chris Delcher; Patricia R Freeman; Jeffery Talbert; Stephen G Henry; Dikea Roussos-Ross
Journal:  Res Social Adm Pharm       Date:  2019-03-26

2.  How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?

Authors:  Robert J Smith; Austin S Kilaru; Jeanmarie Perrone; Breah Paciotti; Frances K Barg; Sarah M Gadsden; Zachary F Meisel
Journal:  Pain Med       Date:  2015-02-17       Impact factor: 3.750

3.  Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making.

Authors:  Gillian J Leichtling; Jessica M Irvine; Christi Hildebran; Deborah J Cohen; Sara E Hallvik; Richard A Deyo
Journal:  Pain Med       Date:  2017-06-01       Impact factor: 3.750

4.  Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention.

Authors:  Mary Jo Larson; Cheryl Browne; Ruslan V Nikitin; Nikki R Wooten; Sarah Ball; Rachel Sayko Adams; Kelly Barth
Journal:  Subst Abus       Date:  2018-05-04       Impact factor: 3.716

Review 5.  Targeting practitioners: A review of guidelines, training, and policy in pain management.

Authors:  Kelly S Barth; Constance Guille; Jenna McCauley; Kathleen T Brady
Journal:  Drug Alcohol Depend       Date:  2017-04-01       Impact factor: 4.492

6.  Using Economic Evaluation to Inform Responses to the Opioid Epidemic in the United States: Challenges and Suggestions for Future Research.

Authors:  Thomas Patton; Paul Revill; Mark Sculpher; Annick Borquez
Journal:  Subst Use Misuse       Date:  2022-02-14       Impact factor: 2.164

7.  Brief intervention medication therapy management: Establishment of an opioid misuse intervention model delivered in a community pharmacy.

Authors:  Amy Kenney; Nicholas Cox; M Aryana Bryan; Gerald Cochran
Journal:  Am J Health Syst Pharm       Date:  2021-02-08       Impact factor: 2.637

8.  Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically.

Authors:  Tristan I Evans; Scott E Hadland; Melissa A Clark; Traci C Green; Brandon D L Marshall
Journal:  Harm Reduct J       Date:  2016-07-26

9.  ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes.

Authors:  M Soledad Cepeda; Paul M Coplan; Nathan W Kopper; Jean-Yves Maziere; Gregory P Wedin; Laura E Wallace
Journal:  Pain Med       Date:  2017-01-01       Impact factor: 3.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.